Long Non Coding RNA in Complications of Systemic Lupus

• Sponsor: Cairo University (Other)
• Overall Status: Unknown status
• CT.gov ID: NCT03185767
• Collaborator: (none)
• Enrollment: 100
• Location: 1
• Arms: 2
• Anticipated Duration (Months): 13
• Patients Per Site Per Month: 7.7

Study Details

Study Description

Brief Summary

the precise role of RNA in setting of this complication in systemic lupus erythematosus (SLE) is largely unknown

Condition or Disease	Intervention/Treatment	Phase
Complication in Systemic Lupus Erythematosus	Other: blood sampling	N/A

Study Design

• Study Type: Interventional
• Anticipated Enrollment: 100 participants
• Allocation: Randomized
• Intervention Model: Parallel Assignment
• Masking: Single (Participant)
• Primary Purpose: Diagnostic
• Official Title: Long Non Coding RNA IN Systemic Lupus
• Actual Study Start Date: Jun 1, 2016
• Anticipated Primary Completion Date: Jun 30, 2017
• Anticipated Study Completion Date: Jul 1, 2017

Arms and Interventions

Arm	Intervention/Treatment
Other: SLE group	Other: blood sampling; blood sampling
Other: control group	Other: blood sampling; blood sampling

Outcome Measures

Primary Outcome Measures

1. non coding RNA expression by real time PCR [1 year]

   non coding RNA expression by real time PCR to evaluate thier role in lupus

Eligibility Criteria

Criteria

• Ages Eligible for Study: 18 Years to 60 Years
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: Yes

Inclusion Criteria:

• with systemic lupus

Exclusion Criteria:

vasculitis

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Cairo University	Cairo		Egypt	202

Sponsors and Collaborators

• Cairo University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

• Responsible Party: mai ahmec, teaching assistant, Cairo University
• ClinicalTrials.gov Identifier: NCT03185767
• Other Study ID Numbers: 12345SLE
• First Posted: Jun 14, 2017
• Last Update Posted: Jun 14, 2017
• Last Verified: Jun 1, 2017

• Individual Participant Data (IPD) Sharing Statement: No
• Plan to Share IPD: No
• Studies a U.S. FDA-regulated Drug Product: No
• Studies a U.S. FDA-regulated Device Product: No
• Additional relevant MeSH terms: Lupus Erythematosus, Systemic

Study Results

No Results Posted as of Jun 14, 2017